Skip to main navigation Skip to search Skip to main content

Phase 2, open label study of orally administered PAX-1 monotherapy in patients with recurrent glioblastoma

  • Ahern, Elizabeth (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusFinished
Effective start/end date5/06/21 → 4/06/26

Keywords

  • phase 2 study
  • clinical trial
  • glioblastoma

Clinical Trial Phase

  • Phase II